Charles Green, MD
Family Medicine · Andover, KSNPI 1568499267
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Sanofi US Services Inc. accounts for 67.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $4,841 and has fallen 71.2% since, to $1,396 in 2023. Among family medicine clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $130.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$4K
- GSK$1K
- Novo Nordisk$130
- Comsort, Inc$100
- Takeda Pharmaceuticals U.S.A., Inc.$55
- Amgen$55
- plus $272 from 12 others
What the payments were for
- Consulting fees$1,49624%
- Speaking & faculty fees$3,04949%
- Travel & lodging$71711%
- Food & beverage$99616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 7 | $4,250 |
| GSK | 2 | $1,396 |
| Novo Nordisk | 9 | $130 |
| Comsort, Inc | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Amgen(2 entities) | 4 | $55 |
| Boehringer Ingelheim | 3 | $41 |
| Pfizer | 3 | $33 |
| Merck | 4 | $32 |
| Lilly USA, LLC | 2 | $30 |
| AstraZeneca | 2 | $26 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Novartis | 1 | $15 |
| AbbVie | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Tris Pharma Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NO PRODUCT DISCUSSED$4,121
- ROTATEQ$100
- PNEUMOVAX 23$100
How this compares
$6,258 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 11 | $0 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Andover
- Kari ClouseAndover$12K
- Stephen LemonsAndover$11K
- Christopher MeyerAndover$10K
- Bradley HarrisonManhattan$314K
- Mila MeansWichita$241K
- Scott AveryJunction City$195K
- Kent KiracofeManhattan$189K
- Terry McGeeneyLeawood$147K
- Cole GillenwaterWichita$62K
- David StricklandLawrence$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.